Guest editorial: The thyroid-cholesterol connection: An association between varying degrees of hypothyroidism and hypercholesterolemia in women

Journal of Women's Health

Volumn 9, Issue 4, 2000, Pages 333-336

  Dickey, Richard A ^a   Feld, Stanley ^a  

^a American Association of Clinical Endocrinologists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; THYROTROPIN;

AGE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; EDITORIAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; PRIORITY JOURNAL; THYROID GLAND;

AGING; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; WOMEN'S HEALTH;

EID: 0034100081     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/15246090050020619     Document Type: Editorial

References (27)

1. American Association of Clinical Endocrinologists Guidelines at www.aace.com
2. Mason RL, Hunt HM, Huexthal L. Blood cholesterol values in hyperthyroidism and hypothyroidism. Their significance. N Engl J Med 1930;203:1273.
3. Elder J, McLelland A, St J O'Reilly D, Packard CJ, Series JJ, Shepard J. The relationship between serum cholesterol and serum thyrotropin, thyroxine, and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990;36:4 (Pt 2):110.
4. Kutty KM, Bryant DG, Farid NR. Serum lipids in hypothyroidism. J Clin Endocrinol Metab 1978;46:55.
5. Lithell H, Boberg J, Hellsing K. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein lipase activity in overt and subclinical hypothyroidism: The effect of substitution therapy. Eur J Clin Invest 1981;11:3.
6. Muls E, Rosseneu M, Blaton V, Lesaffre E, Lamberights G, De Moor P. Serum Lipids and apolipoproteins A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 1984;14:12.
7. Packard CJ, Sheppard J, Lindsay GM, Gaw A, Taskinen M-R. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993;76:1209.
8. Gershengorn MC, Ballantyne CM. Thyroid hormone and hypercholesterolemia: Trends in recognition and treatment. Thyroid Update. 1995;2:2-6.
9. Kuusi T, Taskinen MR, Nikkila EA. Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988;66:51.
10. Valdemanson S, Hansson P, Hedner P, Nilsson-Ehle P. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol 1983;104:50.
11. Wiseman S, Powell JT, Humphries SE, Press M. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab 1993;77:108.
12. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:631.
13. Walton KW, Scott P, Dykes PW, Davies JWL. The significance of alterations in serum lipids in thyroid dysfunction II: Alterations of the metabolism and turnover of 1311 low-density lipoproteins in hypothyroidism and thyroitoxicosis. Clin Sci 1965;29:217.
14. Scarabottolo I, Trezzi PR, Catapano AL. Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis 1986;59:329.
15. Day R, Gebhard RL, Schwartz HL, et al. Time course of hepatic 3-hydroxyl-3-methylgluraryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectonized rats after triiodothyronine administration: Possible linkage of cholesterol synthesis to biliary secretion. Endocrinology 1989;125:459.
16. Physician's desk reference, 54th ed. Montvale, NJ: Medical Economics Co Inc, 2000:2350.
17. Arem N, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Intern Med 1990;150:2097.
18. Kinlaw W III. Thyroid disorders and cholesterol: Identifying the realm of clinical relevance. Endocrinologist 1995;5:147.
19. Wood LC, Cooper DS, Ridgway C. Your thyroid. New York: Ballantine Books, 1995.
20. National Center for Health Statistics. Vital statistics of the United States. 1992. Vol II. Mortality, Part A. Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, 1996. DHHS publication 96-1101.
21. Miller BA, ed. SEER cancer statistics review 1973-1990. US Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1993.
22. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 participants with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383.
23. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001.
24. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349.
25. Series JJ, Biggart EM, O'Reilly DS, Packard CJ, Shepard J. Thyroid dysfunction and hypercholesterolemia in the general population of Glasgow, Scotland. Clin Chim Acta 1988;172:217.
26. Van Healst A, Neve P, Chailly P, Basteine PA. Coronary artery disease in hypothyroidism. Lancet 1967;2:800.
27. Hak EA, Pols H, Visser T, Drexhege HA, Hoffman A, Witteman J. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000;132:270.